Feedback / Questions
SY-5933 - Shouyao Holdings
conteltinib (SY-707) - Centaurus Biopharma, Shouyao Holdings
http://clinicaltrials.gov/ct2/show/NCT06970132
May 14, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next